340 related articles for article (PubMed ID: 10789829)
21. Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in guinea pig brain.
Sim LJ; Childers SR
J Comp Neurol; 1997 Oct; 386(4):562-72. PubMed ID: 9378852
[TBL] [Abstract][Full Text] [Related]
22. Standard opioid agonists activate heteromeric opioid receptors: evidence for morphine and [d-Ala(2)-MePhe(4)-Glyol(5)]enkephalin as selective μ-δ agonists.
Yekkirala AS; Kalyuzhny AE; Portoghese PS
ACS Chem Neurosci; 2010 Feb; 1(2):146-54. PubMed ID: 22816017
[TBL] [Abstract][Full Text] [Related]
23. Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor.
Matthes HW; Smadja C; Valverde O; Vonesch JL; Foutz AS; Boudinot E; Denavit-Saubié M; Severini C; Negri L; Roques BP; Maldonado R; Kieffer BL
J Neurosci; 1998 Sep; 18(18):7285-95. PubMed ID: 9736649
[TBL] [Abstract][Full Text] [Related]
24. Interaction of co-expressed mu- and delta-opioid receptors in transfected rat pituitary GH(3) cells.
Martin NA; Prather PL
Mol Pharmacol; 2001 Apr; 59(4):774-83. PubMed ID: 11259622
[TBL] [Abstract][Full Text] [Related]
25. Modulation by neuropeptide FF of the interaction of mu-opioid (MOP) receptor with G-proteins.
Kersanté F; Moulédous L; Zajac JM; Mollereau C
Neurochem Int; 2010; 56(6-7):768-73. PubMed ID: 20211672
[TBL] [Abstract][Full Text] [Related]
26. Differential activation of G-proteins by mu-opioid receptor agonists.
Saidak Z; Blake-Palmer K; Hay DL; Northup JK; Glass M
Br J Pharmacol; 2006 Mar; 147(6):671-80. PubMed ID: 16415903
[TBL] [Abstract][Full Text] [Related]
27. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
Traynor JR; Nahorski SR
Mol Pharmacol; 1995 Apr; 47(4):848-54. PubMed ID: 7723747
[TBL] [Abstract][Full Text] [Related]
28. Galpha(14) links a variety of G(i)- and G(s)-coupled receptors to the stimulation of phospholipase C.
Ho MK; Yung LY; Chan JS; Chan JH; Wong CS; Wong YH
Br J Pharmacol; 2001 Apr; 132(7):1431-40. PubMed ID: 11264236
[TBL] [Abstract][Full Text] [Related]
29. Differences in G-protein activation by mu- and delta-opioid, and cannabinoid, receptors in rat striatum.
Sim LJ; Selley DE; Xiao R; Childers SR
Eur J Pharmacol; 1996 Jun; 307(1):97-105. PubMed ID: 8831110
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effects of opioids on voltage-dependent Ca(2+) channels and catecholamine secretion in cultured porcine adrenal chromaffin cells.
Kitamura G; Ohta T; Kai T; Kon Y; Ito S
Brain Res; 2002 Jun; 942(1-2):11-22. PubMed ID: 12031848
[TBL] [Abstract][Full Text] [Related]
31. Opioid-induced down-regulation of RGS4: role of ubiquitination and implications for receptor cross-talk.
Wang Q; Traynor JR
J Biol Chem; 2011 Mar; 286(10):7854-7864. PubMed ID: 21209077
[TBL] [Abstract][Full Text] [Related]
32. Evidence for mu-, delta-, and kappa-opioid receptors in a human neuroblastoma cell line.
Baumhaker Y; Wollman Y; Goldstein MN; Sarne Y
Life Sci; 1993; 52(19):PL205-10. PubMed ID: 8387137
[TBL] [Abstract][Full Text] [Related]
33. The bovine mu-opioid receptor: cloning of cDNA and pharmacological characterization of the receptor expressed in mammalian cells.
Onoprishvili I; Andria ML; Vilim FS; Hiller JM; Simon EJ
Brain Res Mol Brain Res; 1999 Nov; 73(1-2):129-37. PubMed ID: 10581406
[TBL] [Abstract][Full Text] [Related]
34. Differential binding properties of oripavines at cloned mu- and delta-opioid receptors.
Lee KO; Akil H; Woods JH; Traynor JR
Eur J Pharmacol; 1999 Aug; 378(3):323-30. PubMed ID: 10493109
[TBL] [Abstract][Full Text] [Related]
35. Coincident signalling between the Gi/Go-coupled delta-opioid receptor and the Gq-coupled m3 muscarinic receptor at the level of intracellular free calcium in SH-SY5Y cells.
Yeo A; Samways DS; Fowler CE; Gunn-Moore F; Henderson G
J Neurochem; 2001 Mar; 76(6):1688-700. PubMed ID: 11259487
[TBL] [Abstract][Full Text] [Related]
36. Differential coupling of mu-, delta-, and kappa-opioid receptors to G alpha16-mediated stimulation of phospholipase C.
Lee JW; Joshi S; Chan JS; Wong YH
J Neurochem; 1998 May; 70(5):2203-11. PubMed ID: 9572309
[TBL] [Abstract][Full Text] [Related]
37. Antagonistic property of buprenorphine for putative epsilon-opioid receptor-mediated G-protein activation by beta-endorphin in pons/medulla of the mu-opioid receptor knockout mouse.
Mizoguchi H; Wu HE; Narita M; Hall FS; Sora I; Uhl GR; Nagase H; Tseng LF
Neuroscience; 2002; 115(3):715-21. PubMed ID: 12435410
[TBL] [Abstract][Full Text] [Related]
38. Coupling efficacy and selectivity of the human mu-opioid receptor expressed as receptor-Galpha fusion proteins in Escherichia coli.
Stanasila L; Lim WK; Neubig RR; Pattus F
J Neurochem; 2000 Sep; 75(3):1190-9. PubMed ID: 10936202
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of calcium channels by opioid- and adenosine-receptor agonists in neurons of the nucleus accumbens.
Chieng B; Bekkers JM
Br J Pharmacol; 2001 Jun; 133(3):337-44. PubMed ID: 11375249
[TBL] [Abstract][Full Text] [Related]
40. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.
Alt A; McFadyen IJ; Fan CD; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2001 Jul; 298(1):116-21. PubMed ID: 11408532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]